Discover
NXTC
NextCure, Inc.
1.95
2 x 1.49
2 x 2.57
bid
ask
+
0.35
21.87%
2 @ 04:00 PM
1.85 -0.10 (5.13%)
| Ytd | -86.26% | |
| 1y | -62.72% |
1.61
day range
2.10
1.55
52 week range
15.74
| Open | 1.61 | Prev Close | 1.60 | Low | 1.61 | High | 2.10 | Mkt Cap | 7.04M |
| Vol | 77.97K | Avg Vol | 99.02K | EPS | -16.82 | P/E | N/A | Forward P/E | -0.66 |
| Beta | 0.79 | Short Ratio | 1.89 | Inst. Own | 57.52% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-04 | 50-d Avg | 6.24 | 200-d Avg | 9.68 | 1yr Est | 3.33 |
NXTC News
benzinga.com
What's Going On With NextCure Stock Wednesday?
NextCure ($NXTC) rises 2.1% premarket after presenting positive Phase 1 clinical data for ovarian ca
benzinga.com
12 Health Care Stocks Moving In Monday's Intraday Session
benzinga.com
NextCure, Simcere Zaiming Pharmaceutical Present Phase 1 Dose Escalation Data For SIM0505 At America
NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering a